Enhancement of endothelial cell migration by constitutively active LPA 1-expressing tumor cells

Biochemical and Biophysical Research Communications

Volumn 422, Issue 2, 2012, Pages 339-343

  Kitayoshi, Misaho ^a   Kato, Kohei ^a   Tanabe, Eriko ^a   Yoshikawa, Kyohei ^a   Fukui, Rie ^a   Fukushima, Nobuyuki ^a   Tsujiuchi, Toshifumi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

B103; Cell migration; Endothelial cell; LPA; LPA receptor; LPA 1; PCR; RT; VEGF

Indexed keywords

LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID RECEPTOR 3; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL COUNT; CELL CULTURE; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

RATTUS;

EID: 84861696488     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.012     Document Type: Article

References (28)

1. Lin M.-E., Herr D.R., Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010, 91:130-138.
2. Ishii I., Fukushima N., Ye X., Chun J. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 2004, 73:321-354.
3. Fukushima N., Ishii I., Contos J.A., Weiner J.A., Chun J. Lysophospholipid receptors. Annu. Rev. Pharmacol. Toxicol. 2001, 41:507-534.
4. Noguchi K., Herr D., Mutoh T., Chun J. Lysophosphatidic acid (LPA) and its receptors. Curr. Opin. Pharmacol. 2009, 9:15-23.
5. Ishii S., Noguchi K., Yanagida K. Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat. 2009, 89:57-65.
6. J.J.A. Contos, I. Ishii, J. Chun J. Lysophosphatidic acid receptors, Mol. Pharmacol. 58 (2000) 1188-1196.
7. Goetzl E.J., Dolezalova H., Kong Y., Hu Y.L., Jaffe R.B., Kalli K.R., Conover C.A. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res. 1999, 59:5370-5375.
8. Shida D., Watanabe T., Aoki J., Hama K., Kitayama J., Sonoda H., Kishi Y., Yamaguchi H., Sasaki S., Sako A., Konishi T., Arai H., Nagawa H. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab. Investigation 2004, 84:1352-1362.
9. Panupinthu N., Lee H.Y., Mills G.B. Lysophosphatidic acid production and action: critical new plays in breast cancer initiation and progression. Br. J. Cancer 2010, 102:941-946.
10. Tsujino M., Fujii M., Okabe K., Mori T., Fukushima N., Tsujiuchi T. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells. Virchows Arch. 2010, 457:669-676.
11. Tsujiuchi T., Shimizu K., Onishi M., Sugata E., Fujii H., Mori T., Honoki K., Fukushima N. Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. Biochem. Biophys. Res. Commun. 2006, 349:1151-1155.
12. Okabe K., Hayashi M., Wakabayashi N., Yamawaki Y., Teranishi M., Fukushima N., Tsujiuchi T. Different expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in mouse tumor cells. Pathobiology 2010, 77:278-282.
13. Fang X., Gaudette D., Furui T. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann. NY Acad. Sci. 2000, 905:188-208.
14. Fang X., Schummer M., Mao M., Yu S., Tabassam F.H., Swaby R., Hasegawa Y., Tanyi J.L., LaPushin R., Eder A., Jaffe R., Erickson J., Mills G.B. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim. Biophys. Acta 2002, 1582:257-264.
15. Yamada T., Furukawa M., Hotta M., Yamasaki A., Honoki K., Fukushima N., Tsujiuchi T. Mutations of lysophosphatidic acid receptor-1 gene during progression of lung tumors in rats. Biochem. Biophys. Res. Commun. 2009, 378:424-427.
16. Obo Y., Yamada T., Furukawa M., Hotta M., Honoki K., Fukushima N., Tsujiuchi T. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors. Mutat. Res. 2009, 660:47-50.
17. Wakabayashi N., Tsujino M., Tajiri M., Taki M., Koshino A., Ikeda H., Fukushima N., Tsujiuchi T. No mutations of lysophosphatidic acid receptor genes in lung adenocarcinomas induced by N-nitrosobis-(2-hydroxypropyl)amine in rats. J. Toxicol. Pathol. 2010, 3:63-66.
18. Shano S., Hatanaka K., Ninose S., Moriyama R., Tsujiuchi T., Fukushima N. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim. Biophys. Acta 2008, 1783:748-759.
19. Hayashi M., Okabe K., Kato, Okumura M., Fukui R., Honoki K., Fukushima N., Tsujiuchi T. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett. 2012, 316:91-96.
20. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 1971, 285:1182-1186.
21. Kato K., Fukui R., Okabe K., Tanabe E., Kitayoshi M., Fukushima N., Tsujiuchi T. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2. Biochem. Biophys. Res. Commun. 2012, 417:790-793.
22. Tei K., K-Kimura N., Taguchi O., Kumamoto K., Higashiyama S., Taniguchi N., Toda K., Kawata R., Hisa Y., Kannagi R. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res. 2002, 62:6289-6296.
23. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
24. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362:841-844.
25. Hu Y.-L., Albanese C., Pestell R.G., Jaffe R.B. Dual mechanisms for lysophosphatidic acid stimulation on human ovarian carcinoma cells. J. Natl. Cancer Inst. 2003, 95:733-740.
26. S.Yu, Murph M.M., Lu Y., Liu S., Hall H.S., Liu J., Stephens C., Fang X., Mills G.B. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J. Natl. Cancer Inst. 2008, 100:1630-1642.
27. Shida D., Kitayama J., Yanaguchi H., Okaji Y., Tsuno N.H., Watanabe T., Takuwa Y., Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003, 63:1706-1711.
28. 1/3, COX-2, and NF-κB activation-and EGFR transactivation-dependent mechanisms. Cell Signal. 2008, 20:1804-1814.